Latest News
Rogers Faces Subscriber Growth Concerns After Richmond Fiber Outage
A fiber cut in Richmond, BC has renewed scrutiny on Rogers' network stability as Q2 internet additions fell 35%. Investors watch for impact on churn and retention.
BILL Holdings Buyback at $35.71 as FY27 Growth Slows
BILL Holdings repurchased 8.4 million shares at $35.71 average, but FY27 core revenue growth is expected to slow to 12.6% midpoint.
Early Gasoline Rule Shift Threatens Refiners' Premiums
EPA's early switch to winter-grade gasoline could erase $22B in refiner valuation premiums for VLO, MPC, PSX. Pump prices may drop, but margins face pressure.
PURR Surges 30% on U.S. Regulatory Hopes, Adding $439M to Market Cap
PURR shares soared 30% Wednesday after President Trump hinted at a U.S. regulatory pathway. The move added $439M to market cap, with a $128M policy premium.
Corus Layoffs Leave Revenue Gap Unaddressed
Corus Entertainment eliminated more positions at Global News and radio but disclosed no cost savings, while Q3 revenue fell C$48.4 million year-over-year.
Morgan Stanley's Dallas Hub Could Reshape 6% of Workforce
Morgan Stanley's planned Dallas hub could house up to 4,800 jobs, about 5.8% of its workforce, with $18.5M in city incentives. The stock dipped 3.16%.
Wolfspeed Stock Tumbles 9% as Q4 Losses Widen Despite AI Surge
Wolfspeed shares dropped 9.4% as Q4 revenue fell 24% and adjusted gross loss hit 20%. AI data-center revenue doubled, but cash burn and low utilization raise concerns.
Silver Surge Lifts Pan American's Spread Past $51/Oz
Silver's rally to $68.92 pushed Pan American Silver's spread over all-in sustaining costs above $51/oz, signaling strong operating leverage.
Gold's Rebound Boosts OceanaGold Philippines' Didipio Margin Past $3,460/oz
Gold's rebound to a near three-month high widened OceanaGold Philippines' Didipio margin to over $3,460/oz, with Q2 profit doubling and output set to rise.
Moderna's $28B Surge: Melanoma Trial Sparks Investor Frenzy
Moderna's market cap jumped $28B after a successful Phase 3 melanoma vaccine trial, but shares remain far above analyst targets.
MPLX's 7.35% Yield Offers Cushion as Monday's $2.25B Debt Deal Looms
MPLX LP (NYSE: MPLX) closed Thursday at $58.60, yielding 7.35%, as a $2.25B debt sale due Monday pushes borrowing costs higher, testing the partnership's high-yield appeal.
JD Sports Market Cap Drops £644M on Profit Warning
JD Sports lost £644M in market value after trimming profit guidance by £50M, with North American sales down 6.8% in Q2.